Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Flaherty

Showing results (51-60 of 714) with videos related to

Pageof 72
Sort By:
Journal of Travel Medicine|August 20, 2021
Is there an association between article citations and altmetrics in travel medicine research?Donatas Galickas, Gerard T Flaherty
Journal of Travel Medicine|April 11, 2018
An analysis of international traveller deaths at the Cliffs of Moher in Ireland, 1993-2017Gerard T Flaherty, Eric Caumes
Nature Reviews. Clinical Oncology|May 25, 2011
BRAF targeted therapy changes the treatment paradigm in melanomaAntoni Ribas, Keith T Flaherty
Biochemical Pharmacology|April 13, 2010
Building on a foundation of VEGF and mTOR targeted agents in renal cell carcinomaKeith T Flaherty, Igor Puzanov
Journal of Travel Medicine|March 18, 2026
Hidden guests: uncovering the microbial reality of hotel environmentsThundon Ngamprasertchai, Gerard T Flaherty
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
Gauging the Long-Term Benefits of Ipilimumab in MelanomaAntoni Ribas, Keith T Flaherty
Seminars in Cutaneous Medicine and Surgery|November 6, 2010
Targeted molecular therapy in melanomaIgor Puzanov, Keith T Flaherty
Cancer|July 15, 2010
BRAF, a target in melanoma: implications for solid tumor drug developmentKeith T Flaherty, Grant McArthur
The British Journal of Dermatology|July 12, 2020
Targeted and immunotherapies in BRAF mutant melanoma: where we stand and what to expectX Bai, K T Flaherty
The British Journal of Dermatology|June 26, 2025
The Rise of New Targets in MelanomaXue Bai, Keith T Flaherty
Pageof 72

Showing results (51-60 of 714) with videos related to

Sort By:
Pageof 72
Journal of Travel Medicine|August 20, 2021
Is there an association between article citations and altmetrics in travel medicine research?Donatas Galickas, Gerard T Flaherty
Journal of Travel Medicine|April 11, 2018
An analysis of international traveller deaths at the Cliffs of Moher in Ireland, 1993-2017Gerard T Flaherty, Eric Caumes
Nature Reviews. Clinical Oncology|May 25, 2011
BRAF targeted therapy changes the treatment paradigm in melanomaAntoni Ribas, Keith T Flaherty
Biochemical Pharmacology|April 13, 2010
Building on a foundation of VEGF and mTOR targeted agents in renal cell carcinomaKeith T Flaherty, Igor Puzanov
Journal of Travel Medicine|March 18, 2026
Hidden guests: uncovering the microbial reality of hotel environmentsThundon Ngamprasertchai, Gerard T Flaherty
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
Gauging the Long-Term Benefits of Ipilimumab in MelanomaAntoni Ribas, Keith T Flaherty
Seminars in Cutaneous Medicine and Surgery|November 6, 2010
Targeted molecular therapy in melanomaIgor Puzanov, Keith T Flaherty
Cancer|July 15, 2010
BRAF, a target in melanoma: implications for solid tumor drug developmentKeith T Flaherty, Grant McArthur
The British Journal of Dermatology|July 12, 2020
Targeted and immunotherapies in BRAF mutant melanoma: where we stand and what to expectX Bai, K T Flaherty
The British Journal of Dermatology|June 26, 2025
The Rise of New Targets in MelanomaXue Bai, Keith T Flaherty
Pageof 72